Aurobindo Pharma, subsidiary made party to litigation proceedings in US

The company was reacting to a media report as per which, bankrupt US drug firm Aceto Corporation has accused Aurobindo Pharma and its founder P V Ramprasad Reddy of sabotage and has sought damages in a case filed in the US.

New Delhi: Drug firm Aurobindo Pharma Friday said the company, it's Director P V Ramprasad Reddy and step-down subsidiary Aurolife Pharma LLC, have been made party to a litigation proceeding in the US.

The drug firm in a regulatory filing, however, said it is yet to receive a copy of the proceeding and denied what it said were 'baseless allegations' against the company.

"Company, Aurolife Pharma LLC, a step-down wholly owned subsidiary in US and P V Ramprasad Reddy, our Director have been made the party to a litigation proceeding in the United States of America," Aurobindo Pharma said in a filing to BSE.

Read Also: Aurobindo Pharma gets 10 observations from USFDA for its Unit 3 at Hyderabad

The company was reacting to a media report as per which, bankrupt US drug firm Aceto Corporation has accused Aurobindo Pharma and its founder P V Ramprasad Reddy of sabotage and has sought damages in a case filed in the US.

"On preliminary examination of the complaint, the company has been advised by its legal advisors that the case appears to be devoid of merits and consists of baseless allegations against the company, Aurolife and P V Ramprasad Reddy alleging fraud, negligent misrepresentation and the failure of the company and Aurolife to fulfil their obligations, inter-alia, under a supply contract entered into with the company", Aurobindo Pharma said.

In a filing on BSE, the company said: "We deny all the contentions and allegations set out and alluded to in the media report."

Read Also: Patent Infringement: AstraZeneca moves court against Aurobindo Pharma on generic version of Daliresp